Related Experiment Video
Updated: Aug 17, 2026

A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
Studies on biosynthetic genes and enzymes of isoprenoids produced by actinomycetes
1Biotechnology Research Center, Toyama Prefectural University, 5180 Kurokawa, Kosugi-machi, Toyama 939-0398, Japan. dairi@pu-toyama.ac.jp
Abstract:
Most Streptomyces strains are equipped with only the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for the formation of isopentenyl diphosphate, a common precursor of isoprenoids. In addition to this pathway, some Streptomyces strains possess the mevalonate (MV) pathway via which isoprenoid antibiotics are produced. We have recently cloned and analyzed the MV pathway gene clusters and their flanking regions from terpentecin, BE-40644, and furaquinocin A producers. All these clusters contained genes coding for mevalonate kinase, mevalonate diphosphate decarboxylase, phosphomevalonate kinase, type 2 IPP isomerase, HMG-CoA reductase, and HMG-CoA synthase. The order of each of the open reading frames (ORFs) is also the same, and the respective homologous ORFs show more than 70% amino acid identity with each other. In contrast to these conservative gene organizations, the biosynthetic genes of terpentecin, BE-40644, and furaquinocin A were located just upstream and/or downstream of the MV pathway gene cluster. These facts suggested that all the actinomycete strains possessing both the MV and MEP pathways produce isoprenoid compounds and the biosynthetic genes of one of these isoprenoids usually exist adjacent to the MV pathway gene cluster. Therefore, when the presence of the MV cluster is detected by molecular genetic techniques, isoprenoids may be produced by the cultivation of these actinomycete strains. During the course of these studies, we identified diterpene cyclases possessing unique primary structures that differ from those of eukaryotes and catalyze unique reactions.
Insights
Streptomyces can produce isoprenoids using the mevalonate (MV) pathway alongside the common MEP pathway. Detecting the MV pathway gene cluster suggests potential isoprenoid production in these actinomycetes.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Most Streptomyces utilize the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for isoprenoid precursor formation.
- Some Streptomyces strains possess the alternative mevalonate (MV) pathway, crucial for producing isoprenoid antibiotics.
Purpose of the Study:
- To analyze the mevalonate (MV) pathway gene clusters and flanking regions in terpentecin, BE-40644, and furaquinocin A producing strains.
- To investigate the organization and conservation of MV pathway genes and their relationship with isoprenoid biosynthetic genes in actinomycetes.
Main Methods:
- Cloning and analysis of MV pathway gene clusters and flanking regions.
- Bioinformatic analysis of open reading frames (ORFs) and amino acid identity.
- Identification of diterpene cyclases through molecular genetic techniques.
Main Results:
- MV pathway gene clusters in terpentecin, BE-40644, and furaquinocin A producers share conserved gene content and order.
- Homologous ORFs within these clusters exhibit high amino acid identity (>70%).
- Isoprenoid biosynthetic genes are located adjacent to the MV pathway gene cluster, and unique diterpene cyclases were identified.
Conclusions:
- Actinomycete strains with both MV and MEP pathways are capable of producing isoprenoid compounds.
- Detection of the MV pathway gene cluster can indicate potential isoprenoid production.
- The study identified novel diterpene cyclases with distinct structures and functions.
Related Concept Videos
Biosynthesis of Lipids
Biosynthesis in Bacteria
Production of Antibiotics
Production of Pharmaceuticals
Amino Acid Biosynthetic Pathways
Biosynthesis of Nucleic Acids
